References

[1] Chen W, Zheng R, Baade P D, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66: 115-132 Google Scholar http://scholar.google.com/scholar_lookup?title=Cancer statistics in China, 2015&author=Chen W&author=Zheng R&author=Baade P D&publication_year=2016&journal=CA Cancer J Clin&volume=66&pages=115-132

[2] Rosenberg S A, Lotze M T, Muul L M, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med, 1985, 313: 1485-1492 Google Scholar http://scholar.google.com/scholar_lookup?title=Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer&author=Rosenberg S A&author=Lotze M T&author=Muul L M&publication_year=1985&journal=N Engl J Med&volume=313&pages=1485-1492

[3] Breakthrough of the year 2013. How we did in 2013 and ······. Science, 2013, 342: 1442 Google Scholar http://scholar.google.com/scholar_lookup?title=Breakthrough of the year 2013. How we did in 2013 and ······&publication_year=2013&journal=Science&volume=342&pages=1442

[4] Porter D L, Levine B L, Kalos M, et al. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia. N Engl J Med, 2011, 365: 725-733 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia&author=Porter D L&author=Levine B L&author=Kalos M&publication_year=2011&journal=N Engl J Med&volume=365&pages=725-733

[5] Borghaei H, Paz-Ares L, Horn L, et al. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer. N Engl J Med, 2015, 373: 1627-1639 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer&author=Borghaei H&author=Paz-Ares L&author=Horn L&publication_year=2015&journal=N Engl J Med&volume=373&pages=1627-1639

[6] Lee J H, Lee J H, Lim Y S, et al. Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma. Gastroenterology, 2015, 148: 1383-1391.e6 CrossRef PubMed Google Scholar http://scholar.google.com/scholar_lookup?title=Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma&author=Lee J H&author=Lee J H&author=Lim Y S&publication_year=2015&journal=Gastroenterology&volume=148&pages=1383-1391.e6